|
|
Prepublished online as a Blood First Edition Paper on April 24, 2003; DOI 10.1182/blood-2002-12-3880.
Previous Article | Table of Contents | Next Article 
Blood, 15 August 2003, Vol. 102, No. 4, pp. 1499-1505
PHAGOCYTES
Expression and function of the endothelial protein C receptor in human neutrophils
Daniel H. Sturn,
Nicole C. Kaneider,
Clemens Feistritzer,
Angela Djanani,
Kenji Fukudome, and
Christian J. Wiedermann
From the Division of General Internal Medicine, Department of Internal Medicine, University of Innsbruck, Austria; and the Department of Immunology, Saga Medical School, Nabeshima, Japan.
Activation of protein C by thrombin bound to thrombomodulin is enhanced by endothelial protein C receptor. This pathway may inhibit inflammation. We investigated effects of protein C and activated protein C on neutrophils as well as whether an endothelial protein C receptor is involved in mediating protein C effects. Neutrophils were from venous blood of healthy donors. Cell migration, respiratory burst, phagocytic activity, and apoptosis were studied by micropore filter assays and fluorometry. Receptor expression was investigated by reverse transcriptasepolymerase chain reaction (PCR) for mRNA, sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and autoradiography of immunoprecipitated receptor protein, and fluorescence-activated cell-sorter scanner (FACS) analysis using the antiendothelial protein C receptor antibody RCR-252. Neither protein C nor activated protein C induced migration, yet both of them inhibited neutrophil chemotaxis triggered by interleukin-8, formyl-Met-Leu-Phe, antithrombin, or C5a. A protein C activationblocking antibody against endothelial protein C receptor diminished inhibitory effects of protein C or activated protein C on migration. No effect of either protein C preparation was seen in neutrophil's respiratory burst, bacterial phagocytosis, or apoptosis assays. Endothelial protein C receptor immunoreactivity was confirmed on neutrophils by FACS. De novo synthesis is suggested by endothelial protein C receptor mRNA expression as demonstrated by reverse transcriptase PCR and immunoprecipitation SDS-PAGE analyses. Data suggest that an endothelial protein C receptor is expressed by human neutrophils whose active site ligation with either protein C or activated protein C arrests directed cell migration. Inhibitory effects of these components of the protein C pathway on neutrophil function may play a role in the protein Cbased treatment of severe sepsis.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Neutrophils and the protein C pathway
- Jeffrey I. Weitz
Blood 2003 102: 1152-1153.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
L. O. Mosnier, B. V. Zlokovic, and J. H. Griffin
The cytoprotective protein C pathway
Blood,
April 15, 2007;
109(8):
3161 - 3172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gruber, U. M. Marzec, L. Bush, E. Di Cera, J. A. Fernandez, M. A. Berny, E. I. Tucker, O. J. T. McCarty, J. H. Griffin, and S. R. Hanson
Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primates
Blood,
April 1, 2007;
109(9):
3733 - 3740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Thiyagarajan, T. Cheng, and B. V. Zlokovic
Endothelial Cell Protein C Receptor: Role Beyond Endothelium?
Circ. Res.,
February 2, 2007;
100(2):
155 - 157.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Stephenson, L. J. Toltl, S. Beaudin, and P. C. Liaw
Modulation of Monocyte Function by Activated Protein C, a Natural Anticoagulant
J. Immunol.,
August 15, 2006;
177(4):
2115 - 2122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Alsfasser, A. L. Warshaw, S. P. Thayer, B. Antoniu, M. Laposata, K. B. Lewandrowski, and C. Fernandez-del Castillo
Decreased Inflammation and Improved Survival With Recombinant Human Activated Protein C Treatment in Experimental Acute Pancreatitis
Arch Surg,
July 1, 2006;
141(7):
670 - 676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. T. Berg, B. Gerlitz, G. R. Sharma, M. A. Richardson, E. J. Stephens, R. L. Grubbs, K. C. Holmes, K. Fynboe, D. Montani, M. S. Cramer, et al.
FoxA2 Involvement in Suppression of Protein C, an Outcome Predictor in Experimental Sepsis.
Clin. Vaccine Immunol.,
March 1, 2006;
13(3):
426 - 432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Feistritzer, B. A. Mosheimer, D. H. Sturn, M. Riewald, J. R. Patsch, and C. J. Wiedermann
Endothelial Protein C Receptor-Dependent Inhibition of Migration of Human Lymphocytes by Protein C Involves Epidermal Growth Factor Receptor
J. Immunol.,
January 15, 2006;
176(2):
1019 - 1025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Abraham
Effects of Recombinant Human Activated Protein C in Human Models of Endotoxin Administration
Proceedings of the ATS,
October 1, 2005;
2(3):
243 - 247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Finigan, S. M. Dudek, P. A. Singleton, E. T. Chiang, J. R. Jacobson, S. M. Camp, S. Q. Ye, and J. G. N. Garcia
Activated Protein C Mediates Novel Lung Endothelial Barrier Enhancement: ROLE OF SPHINGOSINE 1-PHOSPHATE RECEPTOR TRANSACTIVATION
J. Biol. Chem.,
April 29, 2005;
280(17):
17286 - 17293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Perez-Casal, C. Downey, K. Fukudome, G. Marx, and C. H. Toh
Activated protein C induces the release of microparticle-associated endothelial protein C receptor
Blood,
February 15, 2005;
105(4):
1515 - 1522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Mizgerd
APC: braking neutrophils to benefit patients?
Blood,
December 15, 2004;
104(13):
3841 - 3841.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Nick, C. D. Coldren, M. W. Geraci, K. R. Poch, B. W. Fouty, J. O'Brien, M. Gruber, S. Zarini, R. C. Murphy, K. Kuhn, et al.
Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis
Blood,
December 15, 2004;
104(13):
3878 - 3885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. V. de Wouwer, D. Collen, and E. M. Conway
Thrombomodulin-Protein C-EPCR System: Integrated to Regulate Coagulation and Inflammation
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2004;
24(8):
1374 - 1383.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|